𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Candicidin treatment of prostatism: A prospective double-blind placebo-controlled study

✍ Scribed by Jensen, K. M.-E. ;Madsen, P. O.

Publisher
Springer
Year
1983
Tongue
English
Weight
385 KB
Volume
11
Category
Article
ISSN
0300-5623

No coin nor oath required. For personal study only.

✦ Synopsis

The polyene macrolide candicidin was investigated in the treatment of benign prostatic hyperplasia (BPH). Forty-one unselected patients with BPH and prostatism were admitted to a prospective, double-blind placebo-controlled clinical trial. Patients treated with 270 mg candicidin daily for 6 months had a significant decrease in residual urine and a significant increase in maximum flow rate after correction for differences in corresponding bladder volume. Symptoms improved significantly in both the candicidin and the placebo group but no differences in improvement were found between the two groups. The mechanism of the drug's effect is unknown and positive results are much less pronounced than those obtained with surgery. Candicidin appears valuable in the treatment of BPH patients who are a poor surgical risk.

📜 SIMILAR VOLUMES

Hypericum treatment of mild–moderate dep
Hypericum treatment of mild–moderate depression in a placebo–controlled study. A prospective, double–blind, randomized, placebo–controlled, multicentre study
✍ E. Schrader; B. Meier; A. Brattström 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

A prospective, randomized, multicentre, double-blind placebo controlled study is described which compares the ecacy and tolerability of hypericum administered as a concentrated ethanolic extract of St John's wort (ZE117) to patients with mild±moderate depression (ICD-10; F 32 . 0 mild; F 32 . 1 mode

Sulfasalazine in early rheumatoid arthri
Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study
✍ Pekka Hannonen; Timo Möttönen; Mikko Hakola; Martti Oka 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 991 KB

Objective. To investigate the efficacy and tolerability of sulfasalazine (SSZ) in the treatment of early rheumatoid arthritis (RA). Methods. Eighty patients (symptomatic disease <12 months) were randomly assigned to treatment with SSZ or placebo for 48 weeks. Clinical, laboratory, and scintigraphic

Treatment of postinfectious olfactory di
Treatment of postinfectious olfactory disorders with minocycline: A double-blind, placebo-controlled study
✍ Jens Reden; Birgit Herting; Katja Lill; Robert Kern; Thomas Hummel 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Objectives/Hypothesis: Infection of the upper respiratory tract is one of the most common causes of olfactory loss. One of the possible underlying pathologic pathways is an increase of apoptosis of olfactory receptor neurons. Therefore, treatment with the antibiotic minocycline, which has been shown

Rifaximin for the treatment of active po
Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study
✍ Kim L. Isaacs; Robert S. Sandler; Maria Abreu; Michael F. Picco; Stephen B. Hana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## Background: The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of rifaximin in patients with active pouchitis. eighteen patients with

Feverfew (Tanacetum parthenium) as a pro
Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study
✍ D. Palevitch; G. Earon; R. Carasso 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

To assess the effectiveness of feverfew as a prophylactic therapy for migraine, a double-blind placebo controlled cross-over trial was conducted for a period of 4 months. Fifty seven patients who attended an outpatient pain clinic were selected at random and divided into two groups. Both groups were